PA
INBX icon

Perceptive Advisors’s Inhibrx INBX Stock Holding History

Perceptive Advisors’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$97M Sell
1,442,707
-10,000
-0.7% -$742K 1.9% 16
2025
Q4 		$115M Buy
1,452,707
+125,000
+9% +$8.52M 2.05% 12
2025
Q3 		$44.7M Buy
1,327,707
+349,815
+36% +$8.61M 1.29% 27
2025
Q2 		$14M Sell
977,892
-86,134
-8% -$1.11M 0.52% 45
2025
Q1 		$14.9M Hold
1,064,026
– – 0.53% 42
2024
Q4 		$16.4M Hold
1,064,026
– – 0.45% 47
2024
Q3 		$16.7M Hold
1,064,026
– – 0.35% 61
2024
Q2 		$15.1M Buy
+1,064,026
New +$16.6M 0.36% 59

Other funds holding INBX

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Perceptive Advisors's INBX Position: Q1 2026 in Review

Perceptive Advisors reduced its Inhibrx (INBX) stake by 0.69% in Q1 2026, selling an estimated $742K and leaving 1,442,707 shares worth $97M. The position accounts for 1.9% of the portfolio, ranked #16.

Perceptive Advisors first reported a position in INBX in Q2 2024 and has held it in 8 quarters since. The position peaked at $115M in Q4 2025. 135 funds tracked by Wall St. Rank hold INBX as of Q1 2026.

  • Perceptive Advisors held 1,442,707 shares of Inhibrx worth $97M as of Q1 2026.
  • Perceptive Advisors sold 10,000 Inhibrx shares in Q1 2026, an estimated $742K.
  • Inhibrx made up 1.9% of Perceptive Advisors's portfolio in Q1 2026, its #16 holding.
  • Perceptive Advisors first reported a position in Inhibrx in Q2 2024 and has held it in 8 quarters since.
  • Perceptive Advisors's Inhibrx position peaked at $115M in Q4 2025.
  • 135 funds tracked by Wall St. Rank held Inhibrx as of Q1 2026.

Based on Perceptive Advisors's 13F filing for Q1 2026, filed 15 May 2026.